Global Markets Eye Potential TrumpXi Summit Outcomes as Trade Tensions Simmer Nvidias Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Retreat UK Labours Capital Gains Tax Proposal Implications for Investors and Markets Indian Stock Markets Surge on USIran Peace Deal Hopes Sensex Jumps 900 Points Nifty Approaches 24000 Venture Capital Shifts Focus to Unsexy Industries AI and Dealmaking Meet ThinMargin Businesses Astera Labs Shares Surge on AI Infrastructure Optimism GCO Q1 2026 Earnings Strong EPS Beat Sends Mixed Signals Agios Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Rises 6 AXTI Q1 2026 Earnings NarrowerthanExpected Loss Drives Sharp Rally Alamo Group Q1 2026 Earnings Strong EPS Beat Amid Steady Operational Execution NWFL Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment LiveOne Inc LVO Q1 2026 Earnings EPS Surpasses Estimates Despite Net Loss Shares Slide Smith Wesson Brands Inc SWBI Sees Modest Uptick as Stock Tests Key Resistance Hennessy Capital Investment Corp VII Rights HVIIR Gains 3 as Support Holds Near 035 Ross Stores ROST Slips 072 as Retail Sector Faces Mixed Signals Beazer Homes BZH Edges Higher as Housing Sector Finds Footing OneIM Acquisition Corp OIM Holds Steady at 1000 Indicating Stability in SPAC Trading Pet Supplies Retailer Files Chapter 11 Bankruptcy Amid Sector Consolidation Pathward Financial Inc CASH Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Underlying Strength Krystal Biotech KRYS Edges Higher Key Support and Resistance Levels in Focus OptimizeRx OPRX Slips 1 as Stock Tests Key Support Near 465 MasTec MTZ Retreats From Resistance Technicals Signal Caution After 17 Decline Nathans Famous NATH Holds Near 101 as RangeBound Trading Persists BioLineRx BLRX Surges 65 Breaking Out or Approaching Resistance Ardent Health ARDT Holds Near Support as Slight Gain Marks Cautious Session Ironwood Pharmaceuticals IRWD Edges Higher Amid Tight Trading Range LightWave Acquisition Corp LWAC Holds Steady at 1020 Amid Low Volume